Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Sci Rep ; 7(1): 5655, 2017 07 18.
Artigo em Inglês | MEDLINE | ID: mdl-28720883

RESUMO

In this study, we investigated some mechanisms involved in sodium-dependent hypertension of rats exposed to chronic salt (NaCl) intake from weaning until adult age. Weaned male Wistar rats were placed under high (0.90% w/w, HS) or regular (0.27% w/w, Cont) sodium diets for 12 weeks. Water consumption, urine output and sodium excretion were higher in HS rats compared to control. Blood pressure (BP) was directly measured by the arterial catheter and found 13.8% higher in HS vs Cont rats. Ganglionic blockade with hexamethonium caused greater fall in the BP of HS rats (33%), and central antagonism of AT1 receptors (losartan) microinjected into the lateral ventricle reduced BP level of HS, but not of Cont group. Heart rate variability analysis revealed sympathetic prevalence on modulation of the systolic interval. HS diet did not affect creatinine clearance. Kidney histological analysis revealed no significant change in renal corpuscle structure. Sodium and potassium concentrations in CSF were found higher in HS rats despite no change in plasma concentration of these ions. Taken together, data suggest that animals exposed to chronic salt intake to a level close to that reported for human' diet since weaning lead to hypertension, which appears to rely on sodium-driven neurogenic mechanisms.


Assuntos
Anti-Hipertensivos/administração & dosagem , Hipertensão/induzido quimicamente , Potássio/líquido cefalorraquidiano , Cloreto de Sódio na Dieta/administração & dosagem , Sódio/líquido cefalorraquidiano , Animais , Anti-Hipertensivos/uso terapêutico , Determinação da Pressão Arterial , Frequência Cardíaca , Hexametônio/administração & dosagem , Hexametônio/uso terapêutico , Hipertensão/líquido cefalorraquidiano , Hipertensão/tratamento farmacológico , Losartan/administração & dosagem , Losartan/uso terapêutico , Masculino , Ratos , Ratos Wistar , Sódio/urina , Cloreto de Sódio na Dieta/efeitos adversos , Desmame
2.
Sci Rep ; 7: 46051, 2017 04 11.
Artigo em Inglês | MEDLINE | ID: mdl-28397867

RESUMO

There is evidence that diets rich in salt or simple sugars as fructose are associated with abnormalities in blood pressure regulation. However, the mechanisms underlying pathogenesis of salt- and fructose-induced kidney damage and/or consequent hypertension yet remain largely unexplored. Here, we tested the role of oxidative state as an essential factor along with high salt and fructose treatment in causing hypertension. Fischer male rats were supplemented with a high-fructose diet (20% in water) for 20 weeks and maintained on high-salt diet (8%) associate in the last 10 weeks. Fructose-fed rats exhibited a salt-dependent hypertension accompanied by decrease in renal superoxide dismutase activity, which is the first footprint of antioxidant inactivation by reactive oxygen species (ROS). Metabolic changes and the hypertensive effect of the combined fructose-salt diet (20 weeks) were markedly reversed by a superoxide scavenger, Tempol (10 mg/kg, gavage); moreover, Tempol (50 mM) potentially reduced ROS production and abolished nuclear factor-kappa B (NF-κB) activation in human embryonic kidney HEK293 cells incubated with L-fructose (30 mM) and NaCl (500 mosmol/kg added). Taken together, our data suggested a possible role of oxygen radicals and ROS-induced activation of NF-κB in the fructose- and salt-induced hypertension associated with the progression of the renal disease.


Assuntos
Frutose/efeitos adversos , Hipertensão/metabolismo , Hipertensão/patologia , NF-kappa B/metabolismo , Estresse Oxidativo , Cloreto de Sódio/efeitos adversos , Antioxidantes/metabolismo , Pressão Sanguínea , Peso Corporal , Óxidos N-Cíclicos/farmacologia , Dieta , Comportamento de Ingestão de Líquido , Comportamento Alimentar , Regulação da Expressão Gênica/efeitos dos fármacos , Teste de Tolerância a Glucose , Células HEK293 , Humanos , Hipertensão/sangue , Hipertensão/fisiopatologia , Rim/efeitos dos fármacos , Rim/enzimologia , Rim/patologia , Linfócitos/efeitos dos fármacos , Linfócitos/metabolismo , Monócitos/efeitos dos fármacos , Monócitos/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Espécies Reativas de Oxigênio/metabolismo , Marcadores de Spin , Superóxido Dismutase/metabolismo
3.
Redox Rep ; 22(6): 515-523, 2017 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-28403686

RESUMO

Oxidative stress, physical inactivity and high-fat (FAT) diets are associated with hepatic disorders such as metabolic syndrome (MS). The therapeutic effects of physical training (PT) were evaluated in rats with MS induced by FAT diet for 13 weeks, on oxidative stress and insulin signaling in the liver, during the last 6 weeks. FAT-sedentary (SED) rats increased body mass, retroperitoneal fat, mean arterial pressure (MAP) and heart rate (HR), and total cholesterol, serum alanine aminotransferase, glucose and insulin. Livers of FAT-SED rats increased superoxide dismutase activity, thiobarbituric acid-reactive substances, protein carbonyl and oxidized glutathione (GSSG); and decreased catalase activity, reduced glutathione/GSSG ratio, and the mRNA expression of insulin receptor substrate 1 (IRS-1) and serine/threonine kinase 2. FAT-PT rats improved in fitness and reduced their body mass, retroperitoneal fat, and glucose, insulin, total cholesterol, MAP and HR; and their livers increased superoxide dismutase and catalase activities, the reduced glutathione/GSSG ratio and the expression of peroxisome proliferator-activated receptor gamma and insulin receptor compared to FAT-SED rats. These findings indicated adaptive responses to PT by restoring the oxidative balance and insulin signaling in the liver and certain biometric and biochemical parameters as well as MAP in MS rats.


Assuntos
Insulina/metabolismo , Fígado/metabolismo , Natação/fisiologia , Animais , Antioxidantes/metabolismo , Catalase/metabolismo , Dieta Hiperlipídica , Glutationa/metabolismo , Dissulfeto de Glutationa/metabolismo , Masculino , Estresse Oxidativo/fisiologia , Ratos , Superóxido Dismutase/metabolismo
4.
Neurosci Lett ; 642: 142-147, 2017 03 06.
Artigo em Inglês | MEDLINE | ID: mdl-28189741

RESUMO

Redox imbalance in regions of the CNS controlling blood pressure is increasingly recognized as a leading factor for hypertension. Nucleus tractus solitarius (NTS) of the dorsomedial medulla is the main region receiving excitatory visceral sensory inputs that modulate autonomic efferent drive to the cardiovascular system. This study sought to determine the capacity of reduced glutathione, a major bioactive antioxidant, to modulate NTS-mediated control of cardiovascular function in unanaesthetized rats. Male Fischer 344 rats were used for microinjection experiments. Cardiovascular responses to l-glutamate were first used to verify accurate placement of injections into the dorsomedial region comprising the NTS. Next, responses to GSH or vehicle were recorded followed by responses to l-glutamate again at the same site. GSH microinjection increased mean arterial pressure (MAP) compared to vehicle and abrogated responses to subsequent injection of l-glutamate. These data indicate that GSH microinjection into the NTS affects blood pressure regulation by dorsomedial neuronal circuits and blunts l-glutamate driven excitation in this region. These findings raise the possibility that increased antioxidant actions of GSH in NTS could contribute to autonomic control dysfunctions of the cardiovascular system.


Assuntos
Pressão Sanguínea/efeitos dos fármacos , Ácido Glutâmico/farmacologia , Glutationa/farmacologia , Núcleo Solitário/efeitos dos fármacos , Animais , Masculino , Microinjeções , Neurônios/efeitos dos fármacos , Ratos , Ratos Endogâmicos F344
5.
Exp Physiol ; 98(1): 57-66, 2013 01.
Artigo em Inglês | MEDLINE | ID: mdl-22730415

RESUMO

Previous studies have shown that postweaning protein restriction induces changes in the sympathetic nervous system in rats, leading to alterations in cardiovascular parameters. In addition, the renin-angiotensin system is also affected in these animals. Here, we hypothesized that adjustments in the interaction between the RAS and SNS underlie the cardiovascular adaptations observed in rats fed a low-protein diet. Thus, we evaluated the alterations in the mean arterial pressure (MAP) and heart rate of Fisher rats fed a protein-deficient diet before and after systemic administration of the angiotensin-converting enzyme inhibitor enalapril and the angiotensin II (Ang II) type 1 (AT(1)) receptor antagonist losartan alone or in combination with the α(1)-adrenergic receptor antagonist prazosin. Administration of enalapril or losartan decreased the MAP only of rats under protein restriction. Prazosin injection after the infusion of losartan caused a further decrease in the MAP of malnourished rats. In contrast, only the administration of prazosin elicited a reduction in the MAP of control animals. When the sequence of administration of the antagonists was inverted, infusion of prazosin in animals fed the standard or the low-protein diet induced a reduction in the MAP that was further decreased by the subsequent injection of losartan. Importantly, in both protocols the responses of malnourished animals to losartan were markedly greater when compared with the control group. Moreover, these animals presented lower levels of circulating Ang II and a reduced responsiveness to Ang II. In contrast, the expression of AT(1) receptors in the aorta of malnourished animals was increased. Thus, our data suggest that the renin-angiotensin system is an important factor supporting blood pressure in rats fed a low-protein diet and that the sympathetic nervous system activity in these animals is under strong influence of Ang II acting via AT(1) receptors.


Assuntos
Angiotensina II/metabolismo , Pressão Arterial/efeitos dos fármacos , Receptor Tipo 1 de Angiotensina/metabolismo , Antagonistas de Receptores de Angiotensina/farmacologia , Animais , Dieta com Restrição de Proteínas , Enalapril/farmacologia , Frequência Cardíaca/efeitos dos fármacos , Losartan/farmacologia , Masculino , Prazosina/farmacologia , Ratos , Ratos Endogâmicos F344 , Receptor Tipo 1 de Angiotensina/efeitos dos fármacos , Sistema Renina-Angiotensina/fisiologia , Sistema Nervoso Simpático/fisiologia
6.
J Appl Physiol (1985) ; 113(9): 1423-31, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-22984242

RESUMO

The hypothalamic paraventricular nucleus (PVN) is important for maintenance of sympathetic nerve activity (SNA) and cardiovascular function. PVN-mediated increases of SNA often involve the excitatory amino acid L-glutamate (L-glu), whose actions can be positively and negatively modulated by a variety of factors, including reactive oxygen species. Here, we determined modulatory effects of the highly diffusible reactive oxygen species hydrogen peroxide (H(2)O(2)) on responses to PVN L-glu. Renal SNA (RSNA), arterial blood pressure, and heart rate were recorded in anesthetized rats. L-Glu (0.2 nmol in 100 nl) microinjected unilaterally into PVN increased RSNA (P < 0.05), without affecting mean arterial blood pressure or heart rate. Effects of endogenously generated H(2)O(2) were determined by comparing responses to PVN L-glu before and after PVN injection of the catalase inhibitor 3-amino-1,2,4-triazole (ATZ; 100 nmol/200 nl, n = 5). ATZ alone was without effect on recorded variables, but attenuated the increase of RSNA elicited by PVN L-glu (P < 0.05). PVN injection of exogenous H(2)O(2) (5 nmol in 100 nl, n = 4) and vehicle (artificial cerebrospinal fluid) were without affect, but H(2)O(2), like ATZ, attenuated the increase of RSNA to PVN L-glu (P < 0.05). Tonic effects of endogenous H(2)O(2) were determined by PVN injection of polyethylene glycol-catalase (1.0 IU in 200 nl, n = 5). Whereas polyethylene glycol-catalase alone was without effect, increases of RSNA to subsequent PVN injection of L-glu were increased (P < 0.05). From these data, we conclude that PVN H(2)O(2) tonically, but submaximally, suppresses RSNA responses to L-glu, supporting the idea that a change of H(2)O(2) availability within PVN could influence SNA regulation under physiological and/or disease conditions.


Assuntos
Ácido Glutâmico/farmacologia , Peróxido de Hidrogênio/metabolismo , Núcleo Hipotalâmico Paraventricular/efeitos dos fármacos , Núcleo Hipotalâmico Paraventricular/fisiologia , Sistema Nervoso Simpático/efeitos dos fármacos , Sistema Nervoso Simpático/fisiologia , Amitrol (Herbicida)/farmacologia , Animais , Pressão Sanguínea/efeitos dos fármacos , Catalase/administração & dosagem , Catalase/antagonistas & inibidores , Inibidores Enzimáticos/farmacologia , Ácido Glutâmico/administração & dosagem , Ácido Glutâmico/fisiologia , Frequência Cardíaca/efeitos dos fármacos , Peróxido de Hidrogênio/farmacologia , Rim/inervação , Rim/fisiologia , Masculino , Microinjeções , Núcleo Hipotalâmico Paraventricular/anatomia & histologia , Ratos , Ratos Sprague-Dawley
7.
Life Sci ; 81(11): 944-50, 2007 Aug 23.
Artigo em Inglês | MEDLINE | ID: mdl-17822720

RESUMO

Earlier studies from the authors' laboratory showed that malnourishment induces alterations in the cardiovascular homeostasis increasing the basal mean arterial pressure and heart rate. In this study, the authors evaluated whether the sympathetic and parasympathetic efferent activities contribute to changes in the cardiovascular homeostasis through altered modulation of the arterial baroreflex of malnourished rats. After weaning, male Fischer rats were given 15% (Normal Protein--NP) or 6% (Low Protein--LP) protein diet for 35 d. The baroreflex gain and latency were evaluated before and after selective autonomic blockades in control and malnourished rats. It was observed that malnourishment affected the baroreflex gain in response to activation and deactivation of the arterial baroreflex. Moreover, malnourished rats showed increased baroreflex latency as compared to that of control rats. Regarding the autonomic efferent activity directed to the heart, the data showed increased sympathetic and decreased parasympathetic efferent activities in malnourished rats, and such alterations could be related to the observed changes in the arterial baroreflex gain as well as in the basal mean arterial pressure and heart rate.


Assuntos
Derivados da Atropina/farmacologia , Barorreflexo/efeitos dos fármacos , Metoprolol/farmacologia , Proteínas/metabolismo , Animais , Artérias/patologia , Peso Corporal/efeitos dos fármacos , Doenças Cardiovasculares/tratamento farmacológico , Doenças Cardiovasculares/metabolismo , Regulação da Expressão Gênica , Masculino , Pressão , Ratos , Ratos Endogâmicos F344
8.
Medicina (Ribeiräo Preto) ; 39(1): 77-88, jan.-mar. 2006. ilus, tab
Artigo em Português | LILACS | ID: lil-437604

RESUMO

RESUMO: Existem evidências de que a atividade neuronal pode ser modulada pelo estado redox (balanço entre espécies químicas oxidantes e redutoras) das células, influenciando, assim, as diferentes funções biológicas que são controladas pelo sistema nervoso. Essa modulação pode ocorrer por meio de diferentes mecanismos e um deles é a modulação da transmissão sináptica no sístema nervoso central (SNC). As descargas autonômicas que são controladas por mecanismos localizados em diferentes áreas do SNC são fundamentais para o controle da pressão arterial. Um importante neurotransmissor que participa dos mecanismos centrais de controle cardiovascular é o glutamato e a transmissão glutamatérgica pode ser extensamente afetada por espécies reativas de oxigênio, oxidantes que parecem ter um importante papel em processos fisiológicos e patológicos. No presente artigo são apresentados os principais achados experimentais que suportam a hipótese de que as espécies reativas de oxigênio podem modular as funções cardiovasculares por produzir alterações nos mecanismos centrais de controle dos sistemas simpático e parassimpático. Logo, desequilíbrios na sinalização mediada por espécies reativas de oxigênios podem contribuir para o desenvolvimento de doenças cardiovasculares como a hipertensão.


Assuntos
Pressão Arterial , Espécies Reativas de Oxigênio , Ácido Glutâmico , Peróxido de Hidrogênio
9.
J Nutr ; 133(1): 15-20, 2003 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-12514260

RESUMO

Epidemiologic and experimental data suggest that excess iron may contribute to the development of cardiovascular diseases (CVD). Because increased LDL cholesterol, decreased HDL cholesterol and alteration of systolic blood pressure (SBP) have all been implicated as risk factors for atherosclerosis and related CVD, the present study was designed to determine whether excess iron alters serum lipids and SBP in control and hypercholesterolemic rats. Female Fischer rats were divided into four groups. The control group (C) was fed the control diet, the CI group was fed the control diet and given iron dextran injections, the hypercholesterolemic group (H) was fed a 1 g/100 g cholesterol diet, and the HI group was fed the cholesterol diet and given iron dextran injections. The rats were fed the diets for 8 wk and iron dextran injections were given during wk 6 at doses of 10 mg/d for 5 d. Excess iron reduced (P < 0.01) plasma total cholesterol in rats fed the cholesterol diet (5.31 +/- 0.83 and 3.17 +/- 0.31 mmol/L for H and HI, respectively). Excess iron also resulted in a redistribution of cholesterol among the various lipoprotein fractions, with an increase (P < 0.01) in HDL cholesterol (0.56 +/- 0.12 and 0.85 +/- 0.16 mmol/L for H and HI, respectively) and a decrease (P < 0.01) in LDL cholesterol (4.49 +/- 0.77 and 2.09 +/- 0.26 mmol/L for H and HI, respectively). This redistribution also occurred in the rats fed the control diet. The treatments did not affect SBP or heart rate. The high cholesterol diet affected iron homeostasis; group H had lower transferrin saturation than group C (P < 0.01); group HI had a lower serum iron concentration than group CI but did not differ from group H (P < 0.05). Therefore, we conclude that if iron has any effect on CVD, it is not through its influence on serum lipids and blood pressure.


Assuntos
Colesterol/sangue , Hipercolesterolemia/metabolismo , Sobrecarga de Ferro/metabolismo , Ferro/farmacologia , Animais , Pressão Sanguínea/efeitos dos fármacos , Colesterol na Dieta/administração & dosagem , Colesterol na Dieta/farmacologia , Feminino , Homeostase/efeitos dos fármacos , Ferro/administração & dosagem , Ferro/sangue , Sobrecarga de Ferro/sangue , Lipídeos/sangue , Fígado/efeitos dos fármacos , Fígado/enzimologia , Fígado/metabolismo , Ratos , Ratos Endogâmicos F344
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA